Percutaneous patent foramen ovale closure provides definitive therapy with rapid oxygenation improvement for platypnea-orthodeoxia syndrome identified via sitting-position echocardiography.
Does percutaneous PFO closure improve oxygenation in patients with Platypnea-Orthodeoxia Syndrome caused by Patent Foramen Ovale?
Percutaneous PFO closure is an effective definitive therapy for Platypnea-Orthodeoxia Syndrome caused by PFO, leading to rapid oxygenation improvement.
Absolute Event Rate: 0% vs 0%
Sitting-position transesophageal echocardiography is a useful diagnostic method for identifying posture-dependent shunting in POS, and percutaneous PFO closure provides definitive therapy with rapid improvement in oxygenation.
Kakura et al. (Sun,) reported a other. Percutaneous patent foramen ovale closure provides definitive therapy with rapid oxygenation improvement for platypnea-orthodeoxia syndrome identified via sitting-position echocardiography.